Skip to main content
main-content

22.01.2019 | Behavioral Bio-Medical Interface (JL Brown and RJ DiClemente, Section Editors) | Ausgabe 1/2019

Current HIV/AIDS Reports 1/2019

The Association Between Marijuana Use and HIV Continuum of Care Outcomes: a Systematic Review

Zeitschrift:
Current HIV/AIDS Reports > Ausgabe 1/2019
Autoren:
LaTrice Montgomery, Kara Bagot, Jennifer L. Brown, Angela M. Haeny
Wichtige Hinweise
This article is part of the Topical Collection on Behavioral-Bio-Medical Interface

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abstract

Purpose of Review

Approximately 77% of HIV-infected adults report lifetime marijuana use. Given the high rates and social acceptability of marijuana use among HIV-infected individuals, it is important to gain a stronger understanding of if, and how, marijuana impacts HIV care cascade outcomes. The purpose of this study is to systematically review recent articles that assess the relationship between marijuana use and HIV continuum of care outcomes.

Recent Findings

One hundred and ninety articles from PubMed were considered for inclusion, and 15 were included in the review. The studies focus on marijuana use among HIV-infected individuals aware of their serostatus (k = 4), individuals engaged in treatment (k = 1), marijuana use in association with adherence to antiretroviral medications (k = 6), and marijuana use in relation to multiple stages of the HIV care cascade (k = 4). Preliminary findings from the small number of studies revealed an association between marijuana use, especially current heavy use, and HIV seropositivity. However, results from studies assessing marijuana use and treatment engagement and adherence to antiretroviral medications were inconsistent and inconclusive.

Summary

Additional research is needed to assess the nuanced relationship between marijuana use and HIV continuum of care outcomes, especially among subgroups of HIV-infected individuals, such as men who have sex with men and young adults.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2019

Current HIV/AIDS Reports 1/2019 Zur Ausgabe

Behavioral Bio-Medical Interface (JL Brown and RJ DiClemente, Section Editors)

Physiological Changes from Violence-Induced Stress and Trauma Enhance HIV Susceptibility Among Women

The Science of Prevention (JD Stekler and JM Baeten, Section Editors)

The Impact of ACA and Medicaid Expansion on Progress Toward UNAIDS 90-90-90 Goals

Behavioral Bio-Medical Interface (JL Brown and RJ DiClemente, Section Editors)

Substance Use Screening in HIV Care Settings: a Review and Critique of the Literature

The Science of Prevention (JD Stekler and JM Baeten, Section Editors)

A Review of Telehealth Innovations for HIV Pre-Exposure Prophylaxis (PrEP)

Behavioral Bio-Medical Interface (JL Brown and RJ DiClemente, Section Editors)

Interventions to Reduce Drug Use Among Methamphetamine Users at Risk for HIV

  1. Sie können e.Med Innere Medizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

  2. Sie können e.Med Allgemeinmedizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.